Epidemiology and Infection



Blastomycosis in Missouri: epidemiology and risk factors for endemic disease 1


M. V. CANO a1a2p1, G. F. PONCE-DE-LEON a1p2, S. TIPPEN a3, M. D. LINDSLEY a1, M. WARWICK a3p3 and R. A. HAJJEH a1c1
a1 Division of Bacterial and Mycotic Diseases, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, GA, USA
a2 Epidemic Intelligence Service, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, GA, USA
a3 Missouri Department of Health, Jefferson City, MO, USA

Article author query
cano m   [PubMed][Google Scholar] 
ponce-de-leon g   [PubMed][Google Scholar] 
tippen s   [PubMed][Google Scholar] 
lindsley m   [PubMed][Google Scholar] 
warwick m   [PubMed][Google Scholar] 
hajjeh r   [PubMed][Google Scholar] 

Abstract

Between 1992 and 1999, 93 cases of blastomycosis, including 25 laboratory confirmed cases, were identified in Missouri (annual incidence, 0·2/100000 population). Mississippi County in southeastern Missouri had the highest incidence (12/100000) with a much higher rate among blacks than whites in this county (43·2/100000). The mortality rate, 44% was also higher among blacks. To determine risk factors for endemic blastomycosis, a case-control study was conducted among southeastern Missouri residents. Independent risk factors for blastomycosis were black race and a prior history of pneumonia. No environmental exposures or socioeconomic factors were significantly associated with increased risk. The increased risk among blacks may possibly be related to genetic factors, but further studies are needed to clarify this. However, heightened awareness of the disease and a better understanding of the risk factors are important and may lead to earlier diagnosis and start of treatment, possibly improving outcome.

(Accepted May 7 2003)


Correspondence:
c1 Mycotic Diseases Branch, MS C-09, Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, Atlanta, GA 30333, USA.
p1 Current affiliations: M. V. Cano, Division of Global Migration and Quarantine, MS E-03, Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, Atlanta, GA 30333, USA. (Tel.: 404-498-1668; Fax: 404-498-1633; E-mail: mcano@cdc.gov).
p2 G. F. Ponce-de-leon, Office of the Director, MS C-12, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, Atlanta, GA 30333, USA.
p3 M. Warwick, The MITRE Corporation, MS W9 40, 7515 Colshire Drive, McLean, VA 22102, USA.


Footnotes

1 Presented in part: 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, September 2000 (abstract ICAAC00-A-023659-ASM).



Metrics